Article Sidebar

pdf
Date Published: 24/11/2023
Abstract Views: 313
Views pdf: 176
DOI: https://doi.org/10.51298/vmj.v532i1.7315
Issue
Vol. 532 No. 1 (2023)
Section
Các bài báo
How to Cite
Qúach, T. H., Nguyễn, Q. T., Châu, P. T. P., Nguyễn, V. T. H., Nguyễn, H. H. V., Ngô, L. L. U., Phạm, Đình L., & Đặng, T. K. N. (2023). KNEE OSTEOARTHRITIS TREATMENT COSTS AT NGUYEN TRAI HOSPITAL IN THE PERIOD 2022 – 2023. Vietnam Medical Journal, 532(1). https://doi.org/10.51298/vmj.v532i1.7315

KNEE OSTEOARTHRITIS TREATMENT COSTS AT NGUYEN TRAI HOSPITAL IN THE PERIOD 2022 – 2023

Thanh Hưng Qúach1, Quốc Tuấn Nguyễn1, Phạm Thanh Phương Châu1, Võ Thu Hiền Nguyễn1, Hoàng Huỳnh Vân Nguyễn2, Lê Lan Uyên Ngô2, Đình Luyến Phạm2, Thị Kiều Nga Đặng2,
1 Nguyen Trai Hospital, Ho Chi Minh City
2 HCMC University of Medicine and Pharmacy

Main Article Content

Abstract

Introduction: Knee Osteoarthritis (KOA) is one of the common joint and bone diseases worldwide. Materials and Methodology: A retrospective study was conducted using electronic medical records of KOA patients treated on both an outpatient and inpatient basis, collected from March 1, 2022, to May 31, 2023, at Nguyen Trai Hospital to analyze direct healthcare costs from the perspective of the third-party payer (health insurance). Results and Discussions: From March 2022 to May 2023, Nguyen Trai Hospital treated 9,350 outpatient KOA patients who used medications for treatment and admitted 1,429 inpatients to the Department of Internal Medicine – Orthopedics. Most patients were females and over 60 years old. The direct healthcare cost for outpatient patients covered by health insurance was 204,670 VND, accounting for 21.31% of the total cost during the examination period. For inpatient cases, Health Insurance paid 2,423,200 VND for each inpatient receiving knee osteoarthritis treatment, representing 51.64% of the total cost during hospitalization. Conclusion: The study indicates that direct healthcare costs for inpatient osteoarthritis cases constitute a significant proportion and can be burdensome during treatment.

Article Details

Keywords

Direct cost; Knee osteoarthritis; Nguyen Trai Hospital

References

1. Losina E, Thornhill TS, Rome BN, Wright J, Katz JN. The dramatic increase in total knee replacement utilization rates in the United States cannot be fully explained by growth in population size and the obesity epidemic. J Bone Joint Surg Am. 2012;94(3):201.
2. Salmon JH, Rat AC, Sellam J, Michel M, Eschard JP, Guillemin F, Jolly D, Fautrel B. Economic impact of lower-limb osteoarthritis worldwide: a systematic review of cost-of-illness studies. Osteoarthritis Cartilage. 2016;24(9):1500-8.
3. Lanes SF, Lanza LL, Radensky PW, Yood RA, Meenan RF, Walker AM, Dreyer NA. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs. Arthritis Rheum. 1997;40(8):1475-81.
4. Gabriel SE, Crowson CS, Campion ME, O'Fallon WM. Direct medical costs unique to people with arthritis. J Rheumatol. 1997;24(4):719-25.
5. Salmon JH, Rat AC, Charlot-Lambrecht I, Eschard JP, Jolly D, Fautrel B. Cost Effectiveness of Intra-Articular Hyaluronic Acid and Disease-Modifying Drugs in Knee Osteoarthritis. Pharmacoeconomics. 2018;36(11):1321-1331.
6. Bùi Hải Bình. Nghiên cứu điều trị bệnh thoái hóa khớp gối nguyên phát bằng liệu pháp huyết tương giàu tiểu cầu tự thân. Luận án Tiến sỹ Y Học. Đại học Y Hà Nội. 2016.
7. Fransen M, Bridgett L, March L, Hoy D, Penserga E, Brooks P. The epidemiology of osteoarthritis in Asia. Int J Rheum Dis. 2011;14(2):113-21.
8. Loeser RF. Age-related changes in the musculoskeletal system and the development of osteoarthritis. Clin Geriatr Med. 2010;26(3):371-386.